Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subcutaneous infusion of gammaglobulins in management of agammaglobulinaemia.

Literature DB >> 6172685

Subcutaneous infusion of gammaglobulins in management of agammaglobulinaemia.

A G Ugazio, M Duse, R Re, G Mangili, G R Burgio.

Abstract

Entities: Disease

Mesh：

Substances：
gamma-Globulins

Year: 1982 PMID： 6172685 DOI： 10.1016/s0140-6736(82)90793-0

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. X-linked agammaglobulinemia.

Authors: M E Conley; J Rohrer; Y Minegishi
Journal: Clin Rev Allergy Immunol Date: 2000-10 Impact factor: 8.667

2. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

Authors: H M Chapel; G P Spickett; D Ericson; W Engl; M M Eibl; J Bjorkander
Journal: J Clin Immunol Date: 2000-03 Impact factor: 8.317

3. Serum IgG levels and complement activity in hypogammaglobulinaemic patients under substitution therapy.

Authors: A Plebani; L D Notarangelo; M Duse; A Avanzini; M Massa; A G Ugazio
Journal: Clin Exp Immunol Date: 1984-10 Impact factor: 4.330

Review 4. Hypogammaglobulinemia: therapeutic rationale.

Authors: A A Long; J A Denburg; P B Dent
Journal: CMAJ Date: 1987-11-01 Impact factor: 8.262

5. Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

Authors: Richard L Wasserman; Isaac Melamed; Robert P Nelson; Alan P Knutsen; Mary Beth Fasano; Mark R Stein; Mikhail A Rojavin; Joseph A Church
Journal: Clin Pharmacokinet Date: 2011-06 Impact factor: 6.447

6. Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.

Authors: Akhilesh Chouksey; Kimberly Duff; Nancy Wasserbauer; Melvin Berger
Journal: Allergy Asthma Clin Immunol Date: 2005-09-15 Impact factor: 3.406

Subcutaneous infusion of gammaglobulins in management of agammaglobulinaemia.

Review 1. X-linked agammaglobulinemia.

2. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

3. Serum IgG levels and complement activity in hypogammaglobulinaemic patients under substitution therapy.

Review 4. Hypogammaglobulinemia: therapeutic rationale.

5. Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

6. Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.

Review 7. Immunoglobulin replacement therapy in children.

8. Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).

Review 9. New Frontiers in Subcutaneous Immunoglobulin Treatment.

10. Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.